Open AccessCirculating asymmetric dimethylarginine and the risk of preeclampsia: a meta-analysis based on 1338 participants
Author(s) -
Jing Yuan,
Xinguo Wang,
Yudou Xie,
Yuzhi Wang,
Lei Dong,
Hong Li,
Tongyu Zhu
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.16543
Subject(s) - preeclampsia , asymmetric dimethylarginine , medicine , meta analysis , incidence (geometry) , confidence interval , subgroup analysis , gastroenterology , endocrinology , pregnancy , arginine , biochemistry , chemistry , genetics , physics , amino acid , optics , biology
Patients with preeclampsia have higher circulating asymmetric dimethylarginine (ADMA). However, whether circulating ADMA is elevated before the diagnosis of preeclampsia has not been determined.